 What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that companys future growth prospects. Low PE multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.The following stocks are considered to be notable value stocks in the healthcare sector: 1. Genesis Healthcare NYSE: GEN - PE: 1.79 2. Vanda Pharmaceuticals NASDAQ: VNDA - PE: 4.73 3. XBiotech NASDAQ: XBIT - PE: 1.0 4. Salarius Pharmaceuticals NASDAQ: SLRX - PE: 1.74 5. Jaguar Health NASDAQ: JAGX - PE: 0.09Genesis Healthcares earnings per share for Q1 sits at 0.28, whereas in Q4, they were at -0.1. Genesis Healthcare does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.This quarter, Vanda Pharmaceuticals experienced a decrease in earnings per share, which was 0.08 in Q4 and is now 0.01. Vanda Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.XBiotech has reported Q4 earnings per share at -0.63, which has decreased by 320.0 compared to Q3, which was -0.15. XBiotech does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Salarius Pharmaceuticals has reported Q1 earnings per share at -0.22, which has increased by 50.0 compared to Q4, which was -0.44. Salarius Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Jaguar Health saw an increase in earnings per share from -1.62 in Q4 to -0.56 now. Jaguar Health does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.See more from Benzinga 5 Value Stocks In The Real Estate Sector Unusual Options Activity Insight: Facebook Unusual Options Activity Insight: TargetC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 